Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling transitional and joint marginal distributions in repeated categorical data

D Follmann1

  • 1Biostatistics Research Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892.

Statistics in Medicine
|March 15, 1994
PubMed
Summary

This study introduces new statistical models for analyzing repeated measures data in clinical trials, specifically for opiate addiction treatment. These models help understand patient state changes over time and treatment effects on these transitions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.

Blood·2001
Same author

Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.

Circulation·2001
Same author

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.

Journal of the American College of Cardiology·2001
Same author

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

European heart journal·2000
Same author

Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators.

Circulation·2000
Same author

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Journal of the American College of Cardiology·1999

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Longitudinal Data Analysis

Background:

  • Repeated measures endpoints with multiple categories require specialized analysis.
  • Existing models may not fully capture the complexities of patient state changes over time.
  • Opiate addiction treatment trials often involve irregularly observed data.

Purpose of the Study:

  • To develop and apply both marginal and transitional statistical models for analyzing repeated measures data.
  • To assess the effectiveness of opiate addiction treatments by examining changes in patient states.
  • To provide a comprehensive understanding of individual behavior patterns over the course of treatment.

Main Methods:

  • Developed transitional models using a multinomial logit model to predict state changes.

Related Experiment Videos

  • Developed marginal models using a multinomial logit model to estimate probabilities of being in specific states.
  • Applied both models to a clinical trial dataset with three possible states: missing, opiates present, or opiates absent.
  • Accounted for within-individual correlations using established statistical approaches.

    • Main Results:

    • Identified significant covariates that predict changes in patient states over time.
    • Demonstrated how opiate treatments influence both the probability of being in a particular state and the transitions between states.
    • Highlighted the complementary nature of marginal and transitional models for a complete analysis.

    Conclusions:

    • Both marginal and transitional models are essential for a thorough analysis of longitudinal data in clinical trials.
    • The developed models offer a robust framework for understanding patient responses and treatment efficacy in addiction studies.
    • Findings provide insights into how treatment interventions impact patient trajectories and outcomes over time.